Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis

Wiley - Tập 39 Số 11 - Trang 1791-1801 - 1996
M. Hochberg1, Mark Prashker2, Maria Greenwald3, Rancho Mirage3, Marian T. Hannan3, Nancy E. Lane4, Stephen Lindsey5, Daniel J. Lovell6, Elizabeth A. Tindall
1University of Maryland, Baltimore
2VA Medical Center
3Boston University
4University of California at San Francisco
5OCHSNER HEALTH SYSTEM
6Cincinnati Children's Hospital Medical Center

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1093/geronj/45.5.M153

10.7326/0003-4819-112-5-352

10.1136/thx.45.8.573

10.1378/chest.102.5.1426

10.1016/S0049-0172(05)80029-0

Hahn TJ, 1993, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

10.1111/j.1365-2796.1993.tb00738.x

10.1016/S0950-3579(05)80080-9

Lukert BP, 1994, Glucocorticoid‐induced osteoporosis, Rheum Dis Clin North Am, 20, 630, 10.1016/S0889-857X(21)00353-7

Joseph JC, 1994, Corticosteroid‐induced osteoporosis, Am J Hosp Pharm, 51, 188

10.1093/rheumatology/34.1.8

10.1111/j.1365-2796.1995.tb00868.x

Lane NE, 1995, Prevention and management of glucocorticoid‐induced osteoporosis, Bull Rheum Dis, 44, 1

Dequeker J, 1995, Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: bones of contention, J Rheumatol, 22, 1013

HahnBH: Glucocorticoid‐induced osteoporosis.Hosp Pract45–56 1995

Gulko PS, 1996, Glucocorticoid‐induced osteoporosis: pathogenesis, prevention and treatment, Clin Exp Rheumatol, 14, 199

10.1056/NEJM198308043090502

10.1136/ard.45.10.852

10.1002/art.1780280402

Michel BA, 1991, Predictors of fractures in early rheumatoid arthritis, J Rheumatol, 18, 804

Michel BA, 1993, Fractures in rheumatoid arthritis: an evaluation of associated risk factors, J Rheumatol, 20, 1666

10.1136/ard.54.1.49

10.1016/0002-9343(94)90131-7

10.2105/AJPH.85.12.1693

10.1002/art.1780240705

10.1007/BF00542348

10.1016/S0954-6111(05)80255-0

10.1016/S0954-6111(05)80040-X

10.1016/S0091-6749(95)70254-7

Klein RG, 1977, Intestinal calcium absorption in exogenous hypercortisolism: role of 25‐hydroxyvitamin D and corticosteroid dose, J Clin Invest, 64, 655

10.1172/JCI109506

10.1016/0026-0495(83)90221-4

10.1016/0039-128X(91)90117-E

10.1172/JCI109902

10.1016/0039-128X(78)90074-0

10.7326/0003-4819-104-5-648

10.1136/bmj.291.6495.574

10.1007/BF02405069

Gronowicz G, 1995, Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decreases β‐1 integrin levels, Endocrinology, 136, 598, 10.1210/endo.136.2.7530648

Hughes‐Fulford M, 1993, Down regulation of c‐fos and cell growth with upregulation of p53 oncogene in glucocorticoid treated osteoblasts (abstract), J Bone Miner Res, 8, S365

10.1210/endo-112-3-931

10.1007/BF01137966

10.1128/MCB.11.9.4490

10.1002/jbmr.5650110602

10.1016/S0049-0172(96)80001-1

Johnston CC, 1989, Clinical indications for bone mass measurements: a report from the Scientific Advisory Board of the National Osteoporosis Foundation, J Bone Miner Res, 4, 1

10.1007/BF00310253

10.1016/S0002-9343(88)80048-2

Reid IR, 1986, Calcium supplements in the prevention of steroid‐induced osteoporosis, Am J Clin Nutr, 44, 287, 10.1093/ajcn/44.2.287

10.1016/0049-0172(76)90020-2

Adachi JD, 1996, Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup, J Rheumatol, 23, 995

10.1056/NEJM199306173282404

10.1016/0026-0495(81)90144-X

10.7326/0003-4819-118-9-199305010-00002

10.1093/oxfordjournals.aje.a116954

10.1002/jbmr.5650100115

10.1002/jbmr.5650070909

10.1002/art.1780371014

10.1093/oxfordjournals.epirev.a036126

10.1001/archinte.1996.00440100065008

10.1056/NEJM199603143341107

10.1172/JCI118722

10.1093/rheumatology/33.4.348

10.1016/S0002-9343(99)80345-3

Adachi JD, 1994, Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss, J Rheumatol, 21, 1922

10.1016/S0002-9343(99)80154-5

10.1016/S0140-6736(88)92721-3

10.1016/S0140-6736(88)90566-1

10.1007/BF00610377

10.1007/BF02565124

10.1007/BF02529727

Adami S, 1993, Anabolic steroids in corticosteroid‐induced osteoporosis, Wien Med Wochenschr, 44, 395

10.1007/BF01623187

10.1111/j.1532-5415.1986.tb05480.x

10.7326/0003-4819-113-4-308

Pun KK, 1989, Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures, Clin Ther, 11, 205

Sinaki M, 1995, Osteoporosis: Etiology, Diagnosis, and Management

10.1007/BF02555706

10.7326/0003-4819-108-6-824

10.7326/0003-4819-116-12-990

10.1016/S0022-3476(94)70193-8

Kreipe RE, 1992, Bones of today, bones of tomorrow, Am J Dis Child, 146, 22

10.1097/01241398-199101000-00011

Warady BD, 1994, Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy, J Rheumatol, 21, 530

10.1001/jama.1994.03520240070044

Allen DB, 1984, Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid‐treated children, Pediatrics, 89, 416

10.1016/S0889-857X(21)00351-3